1576 related articles for article (PubMed ID: 16838323)
21. Repetitive DNA polymorphisms in following chimerism after allogeneic bone marrow transplantation.
Grubic Z; Stingl K; Cecuk Jelicic E; Zunec R; Kastelan A; Serventi Seiwerth R; Bogdanic V; Labar B; Kerhin Brkljacic V
Clin Transplant; 2005 Oct; 19(5):586-90. PubMed ID: 16146548
[TBL] [Abstract][Full Text] [Related]
22. Rapid quantification of mixed chimerism using multiplex amplification of short tandem repeat markers and fluorescence detection.
Thiede C; Florek M; Bornhäuser M; Ritter M; Mohr B; Brendel C; Ehninger G; Neubauer A
Bone Marrow Transplant; 1999 May; 23(10):1055-60. PubMed ID: 10373073
[TBL] [Abstract][Full Text] [Related]
23. Sex chromosome changes after sex-mismatched allogeneic bone marrow transplantation can mislead the chimerism analysis.
Alpár D; Nagy G; Hohoff C; Kajtár B; Bartyik K; Hermesz J; Jáksó P; Andrikovics H; Kereskai L; Pajor L
Pediatr Blood Cancer; 2010 Dec; 55(6):1239-42. PubMed ID: 20979181
[TBL] [Abstract][Full Text] [Related]
24. Early complete donor hematopoietic chimerism in peripheral blood indicates the risk of extensive graft-versus-host disease.
Balon J; Hałaburda K; Bieniaszewska M; Reichert M; Bieniaszewski L; Piekarska A; Pawłowski R; Hellmann A
Bone Marrow Transplant; 2005 Jun; 35(11):1083-8. PubMed ID: 15821766
[TBL] [Abstract][Full Text] [Related]
25. Increasing mixed chimerism defines a high-risk group of childhood acute myelogenous leukemia patients after allogeneic stem cell transplantation where pre-emptive immunotherapy may be effective.
Bader P; Kreyenberg H; Hoelle W; Dueckers G; Kremens B; Dilloo D; Sykora KW; Niemeyer C; Reinhardt D; Vormoor J; Gruhn B; Lang P; Greil J; Handgretinger R; Niethammer D; Klingebiel T; Beck JF
Bone Marrow Transplant; 2004 Apr; 33(8):815-21. PubMed ID: 14990984
[TBL] [Abstract][Full Text] [Related]
26. Sequence polymorphism systems for quantitative real-time polymerase chain reaction to characterize hematopoietic chimerism-high informativity and sensitivity as well as excellent reproducibility and precision of measurement.
Willasch A; Schneider G; Reincke BS; Shayegi N; Kreyenberg H; Kuci S; Weber G; Van Der Reijden B; Niethammer D; Klingebiel T; Bader P
Lab Hematol; 2007; 13(3):73-84. PubMed ID: 17984038
[TBL] [Abstract][Full Text] [Related]
27. A comparison of chimerism and minimal residual disease between four different allogeneic transplantation methods in patients with chronic myelogenous leukemia in first chronic phase.
Elmaagacli AH; Runkel K; Steckel N; Opalka B; Trenschel R; Seeber S; Schaefer UW; Beelen DW
Bone Marrow Transplant; 2001 Apr; 27(8):809-15. PubMed ID: 11477437
[TBL] [Abstract][Full Text] [Related]
28. Quantitative assessment of hematopoietic chimerism by quantitative real-time polymerase chain reaction of sequence polymorphism systems after hematopoietic stem cell transplantation.
Qin XY; Li GX; Qin YZ; Wang Y; Wang FR; Liu DH; Xu LP; Chen H; Han W; Wang JZ; Zhang XH; Li JL; Li LD; Liu KY; Huang XJ
Chin Med J (Engl); 2011 Aug; 124(15):2301-8. PubMed ID: 22029079
[TBL] [Abstract][Full Text] [Related]
29. Myeloid mixed chimerism is associated with relapse in bcr-abl positive patients after unmanipulated allogeneic bone marrow transplantation for chronic myelogenous leukemia.
Román J; Serrano J; Jiménez A; Castillejo JA; Reina ML; González MG; Rodríguez MC; García I; Sánchez J; Maldonado J; Torres A
Haematologica; 2000 Feb; 85(2):173-80. PubMed ID: 10681725
[TBL] [Abstract][Full Text] [Related]
30. [Evaluation of hematopoietic chimerism after allogeneic bone marrow transplantation by modern molecular techniques (STR-PCR and RQ-PCR)--single center].
Czekalska S; Sacha T; Piatkowska-Jakubas B; Zawada M; Florek I; Cwynar D; Skotnicki AB
Przegl Lek; 2010; 67(12):1282-91. PubMed ID: 21591354
[TBL] [Abstract][Full Text] [Related]
31. [Additional chromosomal changes in impaired chimeric analysis of a patient with relapsed leukemia after bone marrow transplantation].
Higuchi Y; Ito T; Matsuda K; Higuchi T; Hidaka E; Imagawa E; Uhara M; Nakazawa H; Ishida F; Yamauchi K; Sano K; Katsuyama T
Rinsho Ketsueki; 2008 Feb; 49(2):109-14. PubMed ID: 18341042
[TBL] [Abstract][Full Text] [Related]
32. Chimerism analysis by sex determining region Y (SRY) and major histocompatibility complex markers in non-human primates using quantitative real-time polymerase chain reaction.
Sieverkropp AJ; Andrews RG; Gaur L; Shields LE
Tissue Antigens; 2005 Jul; 66(1):19-25. PubMed ID: 15982253
[TBL] [Abstract][Full Text] [Related]
33. Short Tandem Repeat-Polymerase Chain Reaction (STR-PCR) with Quantitative Real Time-Polymerase Chain Reaction (qRT-PCR) Method Using for Chimerism Analysis.
Abatay-Sel F; Savran-Oguz F; Kalayoglu-Besisik S; Mastanzade M; Duvarci-Ogret Y; Yonal-Hindilerden I; Aydin F
Clin Lab; 2019 Sep; 65(9):. PubMed ID: 31532093
[TBL] [Abstract][Full Text] [Related]
34. Detection of chimerism and early engraftment after allogeneic peripheral blood stem cell or bone marrow transplantation by short tandem repeats.
Frankel W; Chan A; Corringham RE; Shepherd S; Rearden A; Wang-Rodriguez J
Am J Hematol; 1996 Aug; 52(4):281-7. PubMed ID: 8701946
[TBL] [Abstract][Full Text] [Related]
35. Quantitative analysis of chimerism using a short tandem repeat method on a fluorescent automated DNA sequencer.
Lobashevsky AL; Senkbeil RW; Townsend JE; Mink CA; Thomas JM
Clin Lab Haematol; 2006 Feb; 28(1):40-9. PubMed ID: 16430459
[TBL] [Abstract][Full Text] [Related]
36. Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendations from a workshop at the 2001 Tandem Meetings of the International Bone Marrow Transplant Registry and the American Society of Blood and Marrow Transplantation.
Antin JH; Childs R; Filipovich AH; Giralt S; Mackinnon S; Spitzer T; Weisdorf D
Biol Blood Marrow Transplant; 2001; 7(9):473-85. PubMed ID: 11669214
[TBL] [Abstract][Full Text] [Related]
37. Detection of mixed chimerism and leukemic relapse after allogeneic bone marrow transplantation in subpopulations of leucocytes by fluorescent in situ hybridization in combination with the simultaneous immunophenotypic analysis of interphase cells.
Kögler G; Wolf HH; Heyll A; Arkesteijn G; Wernet P
Bone Marrow Transplant; 1995 Jan; 15(1):41-8. PubMed ID: 7742754
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of mixed chimerism in bone marrow transplantation program in Croatia.
Grubic Z; Stingl K; Cecuk-Jelicic E; Zunec R; Serventi Seiwerth R; Labar B; Rajic Lj; Brkljacic-Kerhin V
Transplant Proc; 2005 Mar; 37(2):1388-91. PubMed ID: 15848729
[TBL] [Abstract][Full Text] [Related]
39. [Relapse of childhood ALL, AML and MDS after allogeneic stem cell transplantation can be prevented by donor lymphocyte infusion in a critical stage of increasing mixed chimerism].
Beck JF; Klingebiel T; Kreyenberg H; Schaudt A; Wölle W; Niethammer D; Bader P
Klin Padiatr; 2002; 214(4):201-5. PubMed ID: 12165902
[TBL] [Abstract][Full Text] [Related]
40. Refined quantitative fluorescent PCR of Y-chromosome DNA sequences mosaics in Turner's syndrome patients--alternative to real-time PCR.
Vodicka R; Vrtel R; Scheinost O; Zapletalova J; Dusek L; Marie G; Santavy J
J Biochem Biophys Methods; 2004 Aug; 60(2):151-62. PubMed ID: 15262449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
